Ozenci, V <br/><br/>
Multiple sclerosis: pro- and anti-inflammatory cytokines and metalloproteinases are affected differentially by treatment with IFN-beta.  [electronic resource] 

 -  Journal of neuroimmunology  Aug 2000 
 - 236-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0165-5728 
<br/><br/><label>Standard No.: </label>10.1016/s0165-5728(00)00281-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cells, Cultured<br/>Cytokines--metabolism<br/>Female<br/>Gene Expression Regulation--drug effects<br/>Gene Expression Regulation, Enzymologic--drug effects<br/>Humans<br/>In Situ Hybridization<br/>Inflammation--enzymology<br/>Interferon-beta--pharmacology<br/>Interferon-gamma--metabolism<br/>Interleukins--metabolism<br/>Leukocytes, Mononuclear--drug effects<br/>Longitudinal Studies<br/>Male<br/>Matrix Metalloproteinase 3--genetics<br/>Matrix Metalloproteinase 7--genetics<br/>Matrix Metalloproteinase 9--genetics<br/>Matrix Metalloproteinases--genetics<br/>Middle Aged<br/>Multiple Sclerosis--drug therapy<br/>RNA, Messenger--genetics<br/>Tissue Inhibitor of Metalloproteinase-1--genetics<br/>Tumor Necrosis Factor-alpha--metabolism